Carson, R. Et Al. 2013. The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer. MOLECULAR CANCER THERAPEUTICS .

Carson, R., ÇELTİKÇİ, B., Johnston, P. G., Van Schaeybroeck, S., & Dunne, P., (2013). The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer . MOLECULAR CANCER THERAPEUTICS

Carson, Robbie Et Al. "The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer," MOLECULAR CANCER THERAPEUTICS, 2013

Carson, Robbie Et Al. "The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer." MOLECULAR CANCER THERAPEUTICS , 2013

Carson, R. Et Al. (2013) . "The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer." MOLECULAR CANCER THERAPEUTICS .

@conferencepaper{conferencepaper, author={Robbie Carson Et Al. }, title={The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer}, congress name={MOLECULAR CANCER THERAPEUTICS}, city={}, country={}, year={2013}}